Search

Partners in Science grant recipients

Partners in Science grant recipients

October 20, 2017

Two researchers with the Oregon National Primate Research Center received $15,000 grants from the M.J. Murdock Charitable Trust, giving two local teachers experience to take back to their classrooms. (Left to right) Shown are Larry Sherman, Paul Donelson, Rachel Stagner, and Henryk Urbanski. (Image courtesy of Murdock Trust)

Research Week 2017: A new approach to permanent birth control for women

May 02, 2017
On any given day, you can find Jeffrey Jensen, M.D., M.P.H., caring for patients, writing NIH grants, teaching medical students or looking at the latest test results in his lab at the Oregon National Primate Research Center. But what gets him up every morning is his commitment to making birth control safer and more effective for women around the world.
Nancy Haigwood, Ph.D.

Nancy Haigwood, Ph.D.

April 19, 2017

Nancy Haigwood, Ph.D., is director and professor at the Oregon National Primate Research Center in the department of pathobiology and immunology, and an adjunct professor in the department of Molecular Microbiology and Immunology at OHSU. (OHSU/John Valls)

Researchers hone in on when, where Zika virus attacks

March 09, 2017
The Zika virus attacks tissues in the nervous system, male and female reproductive and urinary tracts, muscles, joints and lymph nodes, and persists for at least 35 days, according to a study conducted in a nonhuman primate model by a multidisciplinary team of researchers at OHSU in Portland, Oregon.
 Mark Slifka Ph.D.

Mark Slifka Ph.D.

February 03, 2017
Mark Slifka, Ph.D., Oregon National Primate Research Center senior scientist; OHSU School of Medicine professor of microbiology and immunology.
Vaccine technology developed by OHSU scientists acquired by industry leaders

Vaccine technology developed by OHSU scientists acquired by industry leaders

January 25, 2017
A first-of-its-kind vaccine technology platform developed by renowned scientists at OHSU in Portland, Oregon, has been acquired by Vir Biotechnology, a San Francisco-based biotech startup backed by leading industry investor ARCH Venture Partners and the Bill & Melinda Gates Foundation, a leading funder of global health initiatives.
See More Stories